Here are six recent news updates on key gastroenterology and endoscopy companies.
Boston Scientific launched the AXIOS Stent and Electrocautery Enhanced Delivery System.
SonarMD entered into a partnership agreement with Rockford (Ill.) Gastroenterology Associates.
EndoChoice CEO Mark Gilreath bought 20,000 shares of the company's stock.
Fujifilm Medical Systems U.S.A. added a new high-resolution Double Balloon Endoscope to its Double Balloon Endoscopy technology portfolio.
Findings from a late-stage clinical trial showed treatment with Janssen Biotech's Stelara induced clinical response and remission in adult patients with moderate to severe Crohn's disease refractory to TNF inhibitors.
EndoGastric Solutions presented three-year follow-up data from TEMPO, a prospective, randomized, multicenter clinical study, which showed that the Transoral Incisionless Fundoplication procedure with the EsophyX device was effective in controlling chronic gastroesophageal reflux disease.